Posted on 7/9/20
Tris Pharma and KYE Pharmaceuticals Announce Exclusive License Agreement
Tris Pharma, Inc., a specialty pharmaceutical company with a robust portfolio of FDA-approved products for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related disorders, . . .
Posted on 7/19/20
Capital Rx Establishes Scholarship at Howard University to Support Next Generation of Pharmacists
NEW YORK--(BUSINESS WIRE)--Capital Rx, the fastest-growing pharmacy benefit manager in the U.S., has established the Dr. James McCune Smith Endowed Scholarship fund to support the next . . .
Posted on 7/9/20
Corporate Update From NxGen Brands
NxGen Brands Inc. (OTCPK: NXGB) has registered various products with the U.S. Food and Drug Administration (FDA) to assist with the fight against the current pandemic . . .
Posted on 7/9/20
MJH Life Sciences Acquires Pharmaceutical Commerce
MJH Life Sciences today announced it has acquired Pharmaceutical Commerce, a multimedia platform published by Healthcare Commerce Media Corporation
Posted on 7/9/20
Merck: Amazing Oncology Division, Underwhelming Dividend Opportunity
SummaryMerck, an international pharmaceutical company, has experienced strong growth of key financial metrics over the last few years driven by the success of some of their . . .
Posted on 7/9/20
Voltron Therapeutics Retains Buenaventura Advisors
NEW YORK , July 09, 2020 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. announced today it has retained Buenaventura Advisors, LLC to explore strategic alternatives for HaloVax, a . . .
Posted on 7/9/20
Here's Why Pfizer Fell 14% in June
What happenedShares of Pfizer (NYSE:PFE) dropped 14.4% in June according to data provided by S&P Global Market Intelligence, which is a pretty substantial drop for a . . .
Posted on 7/9/20
Regeneron Lands a $450 Million "Warp Speed" Contract for Its Prospective COVID-19 Treatment
Regeneron Pharmaceuticals (NASDAQ:REGN) announced Tuesday that it had received a $450 million Operation Warp Speed contract for the development and production of REGN-COV2, a COVID-19 treatment . . .
Posted on 7/8/20
Johnson & Johnson: Excellent Company Tarnished By Scandal
SummaryJohnson & Johnson is a high-quality company with low but steady growth and strong margins.The company boasts the highest credit rating available and generates big cash . . .
Posted on 7/8/20
Does Pfizer's COVID-19 Vaccine Make the Big Pharma Stock a Buy?
Any good news in the race to develop a COVID-19 vaccine garners plenty of attention. That's exactly what happened last week after Pfizer (NYSE:PFE) and BioNTech . . .
Posted on 7/7/20
Gracie Square Psychiatrist Offers Advice for Front-Line Health Care Workers Coping with Pandemic’s Emotional and Psychological Impact
Health care workers on the frontline of the COVID-19 crisis face devastating emotional and psychological impact from the pandemic. Although the public has shown appreciation for . . .
Posted on 7/7/20
Bioasis Announces Stock Option Grants
GUILFORD, Conn.--(BUSINESS WIRE)--BIOASIS TECHNOLOGIES INC. (TSXV:BTI.V; OTCQB:BIOAF), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 platform technology for the delivery of therapeutics across the blood-brain . . .
Posted on 7/7/20
Johnson & Johnson: Building Your Core
SummaryJohnson & Johnson is a Dividend Champion with 58 consecutive years of dividend growth. Shares currently yield 2.87%.Johnson & Johnson is one of two AAA-rated companies, . . .
Posted on 7/7/20
Tonix Pharmaceuticals Plans Massachusetts R&D Facility
NEW YORK, July 07, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced its intent . . .
Posted on 7/7/20
Vor Biopharma Raises $110M In Series B
Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, today announced it has raised $110 million in a Series . . .
Posted on 7/6/20
Chembio Diagnostics Awarded BARDA Contract for Development of DPP COVID-19 Point-of-Care Antigen System
HAUPPAUGE, N.Y., July 06, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced it has . . .
Posted on 7/6/20
Pacira BioSciences Proposes Offering of $300M Senior Notes
PARSIPPANY, N.J., July 06, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced that it intends to offer, subject to market and other conditions, . . .
Posted on 7/6/20
NAPA Expands Anesthesia Services to University of Maryland Capital Region Health
MELVILLE, N.Y., July 06, 2020 (GLOBE NEWSWIRE) -- Effective July 6, 2020, North American Partners in Anesthesia (NAPA) will provide anesthesia services for two facilities affiliated . . .
Posted on 7/6/20
Bristol-Myers Squibb: Growth And Valuation Trump Other Concerns
SummaryWhile the Celgene acquisition added blockbusters to the company’s product portfolio, it comes with big debt and integration risk.Bristol’s top three drugs provide 69% of revenues.The . . .
Posted on 7/6/20
Regeneron's Arthritis Drug Fails COVID-19 Trial
A clinical trial with thousands of hospitalized coronavirus patients failed to hit the mark for the last time on Thursday. A group of COVID-19 patients requiring . . .
Posted on 7/5/20
Ten Health Care Stocks to Purchase for a COVID-19 Healing
Ten health care stocks to purchase during the ongoing recovery from the COVID-19 pandemic target companies aimed at treating patients and giving them prescription drugs to . . .
Posted on 7/2/20
Merck Animal Health Completes Acquisition of U.S. Rights to SENTINEL Brand of Combination Parasiticides for Companion Animals
MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA . . .
Posted on 7/2/20
Better Buy: Eli Lilly vs. Johnson & Johnson
As two of the largest healthcare companies in the world, both Eli Lilly (NYSE:LLY) and Johnson & Johnson (NYSE:JNJ) have a role to play in well-balanced . . .
Posted on 7/2/20
Pfizer and BioNTech Post Positive Trial Data for Their COVID-19 Vaccine
In an early-stage phase 1/2 clinical trial, BNT162b1, the COVID-19 vaccine being developed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), produced antibodies against SARS-CoV-2, the novel coronavirus . . .
Posted on 7/2/20
Akari Therapeutics Enters Into a Securities Purchase Agreement for up to $30M with Aspire Capital Fund
NEW YORK and LONDON, July 01, 2020 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics to . . .
New York
